The feared thing keeps not happening: management confronts a specific live worry with current evidence running against i
The model's full reasoning — Q1 2022 call → NO我们根据提供的财报电话会议记录,判断是否存在一个具体的、公司特定的负面担忧,并且管理层是否用已经观察到的证据进行了反驳。 首先,寻找担忧。在电话会议中,分析师Brian Martin多次提问,关注贷款增长、预付款、收益率、费用等。管理层提到第四季度预付款很高,但第一季度和四月份预付款减少。管理层还提到设备金融交易延迟,但四月份设备金融业务强劲。分析师询问了预付款的展望,管理层给出了估计。但这是否是一个具体的担忧?分析师似乎关注增长能否持续,以及预付款是否会影响增长。管理层在回应中提到了四月份贷款增长45百万美元,设备金融四月份比第一季度整个季度还多,以及收益率上升。这似乎是对增长担忧的回应。 但问题要求的是“一个具体的负面结果,投资者、分析师或市场明显担心会发生在这家公司身上”。在电话会议中,是否有这样的担忧?分析师Brian Martin问了很多关于增长、预付款、收益率的问题,但似乎没有明确表达一个具体的恐惧,比如“需求会下降”或“客户会流失”。管理层自己提到了“我们一直以来的目标”,但并没有说市场担心什么。管理层在回应中提到了“我们感到沮丧”关于股票回购,但那是关于资本配置的。 再仔细看:管理层在开头提到“我们看到了四月份贷款增长”,然后说“我们的目标一直是每季度4000万”,并说“我们已经实现了”。分析师问了很多关于预付款的问题,管理层解释了预付款减少的原因。分析师还问到了费用和利润率。但似乎没有明确的一个“恐惧”被命名。 也许担忧是“增长能否持续”或“预付款是否会反弹”,但管理层用四月份的数据回应了。然而,问题要求“担忧是具体的、公司特定的,并且是活跃的”,分析师反复追问可能表明担忧存在。但管理层是否明确承认了这种担忧?在电话会议中,管理层没有说“市场担心我们增长会放缓”之类的话。他们只是提供了数据。 另一个可能的担忧是“设备金融交易延迟”,但管理层说四月份设备金融很强,这算是对延迟的回应,但延迟本身不是负面结果,而是供应链问题。 或许担忧是“贷款组合增长后收益率下降”,但管理层说收益率上升了。 我认为没有明确的一个“恐惧”被命名。分析师的问题更多是询问细节,而不是表达担忧。管理层也没有承认任何担忧。 因此,答案应该是NO。 但让我们再确认一下:是否有分析师直接问“你担心什么?”没有。管理层也没有说“有人担心”。 所以,答案是否定的。
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| AVTR | Avantor, Inc. | Q2 2024 | 2024-07-26 | C+ |
| IFS | Intercorp Financial Services Inc. | Q1 2024 | 2024-05-14 | C+ |
| AZEK | The AZEK Company Inc. | Q2 2024 | 2024-05-08 | B+ |
| GL | Globe Life Inc. | Q1 2024 | 2024-04-23 | F |
| MNKD | MannKind Corporation | Q4 2023 | 2024-02-27 | C |
| NICE | NICE Ltd. | Q4 2023 | 2024-02-22 | B+ |
| TYGO | Tigo Energy, Inc. | Q4 2023 | 2024-02-14 | F |
| MET | MetLife, Inc. | Q4 2023 | 2024-02-01 | B+ |
| BBVA | Banco Bilbao Vizcaya Argentaria, S.A. | Q4 2023 | 2024-01-30 | B+ |
| TBLA | Taboola.com Ltd. | Q3 2023 | 2023-11-08 | B+ |
| GMED | Globus Medical, Inc. | Q3 2023 | 2023-11-07 | B |
| DASH | DoorDash, Inc. | Q3 2023 | 2023-11-01 | C+ |
| MAC | The Macerich Company | Q3 2023 | 2023-10-31 | D |
| LNTH | Lantheus Holdings, Inc. | Q2 2023 | 2023-08-03 | C+ |
| SITM | SiTime Corporation | Q2 2023 | 2023-08-02 | C+ |
| TREX | Trex Company, Inc. | Q2 2023 | 2023-07-31 | B+ |
| REYN | Reynolds Consumer Products Inc. | Q1 2023 | 2023-05-10 | C |
| DOCN | DigitalOcean Holdings, Inc. | Q1 2023 | 2023-05-09 | C+ |
| ULCC | Frontier Group Holdings, Inc. | Q1 2023 | 2023-05-07 | C+ |
| AKR | Acadia Realty Trust | Q4 2022 | 2023-05-06 | B+ |
| BRX | Brixmor Property Group Inc. | Q1 2023 | 2023-05-02 | A |
| EPR | EPR Properties | Q1 2023 | 2023-04-27 | C+ |
| MEDP | Medpace Holdings, Inc. | Q1 2023 | 2023-04-25 | B+ |
| DKS | DICK'S Sporting Goods, Inc. | Q4 2022 | 2023-03-07 | B |
| CRBG | Corebridge Financial, Inc. | Q4 2022 | 2023-02-22 | B |
| POOL | Pool Corporation | Q4 2022 | 2023-02-16 | C+ |
| ADPT | Adaptive Biotechnologies Corporation | Q4 2022 | 2023-02-14 | C+ |
| REGN | Regeneron Pharmaceuticals, Inc. | Q4 2022 | 2023-02-03 | C |
| HBAN | Huntington Bancshares Incorporated | Q4 2022 | 2023-01-20 | B |
| A | Agilent Technologies, Inc. | Q4 2022 | 2022-11-21 | B+ |
| PCTY | Paylocity Holding Corporation | Q1 2023 | 2022-11-05 | A |
| TT | Trane Technologies plc | Q3 2022 | 2022-11-02 | A |
| APOG | Apogee Enterprises, Inc. | Q2 2023 | 2022-09-20 | A |
| CRL | Charles River Laboratories International | Q2 2022 | 2022-08-03 | C |
| SGRY | Surgery Partners, Inc. | Q2 2022 | 2022-08-02 | B+ |
| ZBRA | Zebra Technologies Corporation | Q2 2022 | 2022-08-02 | C+ |
| LIN | Linde plc | Q2 2022 | 2022-07-28 | B+ |
| SHW | The Sherwin-Williams Company | Q2 2022 | 2022-07-27 | D |
| JBHT | J.B. Hunt Transport Services, Inc. | Q2 2022 | 2022-07-19 | C+ |
| OGI | OrganiGram Holdings Inc. | Q3 2022 | 2022-07-14 | B+ |
| KFY | Korn Ferry | Q4 2022 | 2022-06-22 | B |
| SE | Sea Limited | Q1 2022 | 2022-05-17 | F |
| DCGO | DocGo Inc. | Q1 2022 | 2022-05-14 | C |
| ZVIA | Zevia PBC | Q1 2022 | 2022-05-12 | B |
| EGHT | 8x8, Inc. | Q4 2022 | 2022-05-10 | C+ |
| CCRN | Cross Country Healthcare, Inc. | Q1 2022 | 2022-05-04 | B |
| ABNB | Airbnb, Inc. | Q1 2022 | 2022-05-03 | B+ |
| BXP | Boston Properties, Inc. | Q1 2022 | 2022-05-03 | A |
| BSX | Boston Scientific Corporation | Q1 2022 | 2022-04-27 | B |
| CCK | Crown Holdings, Inc. | Q1 2022 | 2022-04-26 | C+ |
| FR | First Industrial Realty Trust, Inc. | Q1 2022 | 2022-04-21 | A |
| SDIG | Stronghold Digital Mining, Inc. | Q3 2021 | 2021-11-30 | F |
| GFS | GLOBALFOUNDRIES Inc. | Q3 2021 | 2021-11-30 | A |
| IPGP | IPG Photonics Corporation | Q3 2021 | 2021-11-02 | C |
| HSY | The Hershey Company | Q3 2021 | 2021-10-28 | C |
| PEP | PepsiCo, Inc. | Q3 2021 | 2021-10-05 | B |
| GDS | GDS Holdings Limited | Q2 2021 | 2021-08-17 | C+ |
| PTVE | Pactiv Evergreen Inc. | Q2 2021 | 2021-08-08 | C+ |
| SPG | Simon Property Group, Inc. | Q2 2021 | 2021-08-02 | B |
| GLW | Corning Incorporated | Q2 2021 | 2021-07-27 | B+ |
| DOV | Dover Corporation | Q2 2021 | 2021-07-20 | B+ |
| VLRS | Controladora Vuela Compañía de Aviación, | Q2 2021 | 2021-07-16 | B+ |
| MAR | Marriott International, Inc. | Q2 2018 | 2018-08-07 | B |
| VALE | Vale S.A. | Q2 2018 | 2018-07-26 | B |
| FICO | Fair Isaac Corporation | Q3 2018 | 2018-07-26 | C+ |
| ORAN | Orange SA | Q2 2018 | 2018-07-26 | B |
| KIM | Kimco Realty Corporation | Q2 2018 | 2018-07-26 | B+ |
| TRUE | TrueCar, Inc. | Q1 2018 | 2018-05-08 | C |
| TGNA | TEGNA Inc. | Q1 2018 | 2018-05-08 | B+ |
| CVS | CVS Health Corporation | Q1 2018 | 2018-05-02 | B+ |
| ALLY | Ally Financial Inc. | Q1 2018 | 2018-04-26 | B+ |
| MIDD | The Middleby Corporation | Q4 2017 | 2018-02-28 | C |
| SBUX | Starbucks Corporation | Q1 2018 | 2018-01-26 | C |
| AVT | Avnet, Inc. | Q2 2018 | 2018-01-25 | B |
| GURE | Gulf Resources, Inc. | Q3 2017 | 2017-11-14 | F |
| HOLX | Hologic, Inc. | Q4 2017 | 2017-11-08 | D |
| MKTX | MarketAxess Holdings Inc. | Q3 2017 | 2017-10-25 | C+ |
| PII | Polaris Inc. | Q3 2017 | 2017-10-24 | C+ |
| LIND | Lindblad Expeditions Holdings, Inc. | Q2 2017 | 2017-08-06 | C |
| BCRX | BioCryst Pharmaceuticals, Inc. | Q1 2017 | 2017-05-07 | B |
| ICFI | ICF International, Inc. | Q1 2017 | 2017-05-06 | B+ |
| CGNT | Cognyte Software Ltd. | Q4 2016 | 2017-03-09 | D |
| BDC | Belden Inc. | Q4 2016 | 2017-02-02 | B |
| CAG | Conagra Brands, Inc. | Q2 2017 | 2016-12-22 | C+ |
| TGI | Triumph Group, Inc. | Q2 2017 | 2016-11-03 | C+ |
| SEM | Select Medical Holdings Corporation | Q1 2016 | 2016-05-06 | C+ |
| LPSN | LivePerson, Inc. | Q1 2016 | 2016-05-04 | B |
| UVE | Universal Insurance Holdings, Inc. | Q1 2016 | 2016-05-03 | C+ |
| ESE | ESCO Technologies Inc. | Q2 2016 | 2016-05-03 | A |
| VRTS | Virtus Investment Partners, Inc. | Q1 2016 | 2016-04-29 | D |
| DD | DuPont de Nemours, Inc. | Q1 2016 | 2016-04-26 | B+ |
| BX | Blackstone Inc. | Q1 2016 | 2016-04-21 | B |
| HPP | Hudson Pacific Properties, Inc. | Q4 2015 | 2016-02-25 | C |
TGI · Q2 2017 → YESThe question is: Is there a specific negative outcome that investors/analysts/market are worried about for THIS company, live on this call, and does management push back with CURRENT, ALREADY-OBSERVED...YES The specific, company-attached fear that is live on the call is that Triumph will continue to face large performance-related charges, cash burn on development programs, and failure to stabilize margins/cash flow despite the transformation (a worry analysts repeatedly probe via questions on the $80M risk, free-cash-use guidance, 747-8/C-17/G650 headwinds, and red programs). Management directly counters it by citing already-observed evidence: Q2 operating income of $70.
ULCC · Q1 2023 → YESThe question is: Is there a SPECIFIC NEGATIVE OUTCOME that investors/analysts/market have been worried about for THIS company, live on this call, AND does management push back with CURRENT, ALREADY-OB...YES The transcript shows a live, company-specific worry about pilot staffing shortages (tied to network changes and new contracts elsewhere) and customer churn/retention due to lower satisfaction scores. Management directly counters both with current evidence: pilot surplus and attrition on target for staffing, plus over 90% repeat business for retention.
HOLX · Q4 2017 → YESThe question is: Is there a SPECIFIC NEGATIVE OUTCOME that investors, analysts, or the market have plainly been worried will happen to THIS company, and does management push back on that worry by poin...YES The transcript shows a live, company-specific fear centered on Cynosure: investors and analysts are worried that the acquisition will not deliver sustainable growth, that recent sequential declines reflect a lasting salesforce collapse or competitive erosion, and that the business will continue underperforming expectations rather than turning around.